MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Leukemia, Experimental

(UMLS:C0023441)

Definition:: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
UMLS ID:: C0023441
MeSH ID:: D007942

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.337.372|C04.619.531

Classification 2:

Name:

Investigative Techniques
MeSH Tree Number(s):: E05.598.500.496.500

Synonym(s)

Leukemia, Experimental

Associated Drug(s)

	Name	Reference(s)	Data Source
1	1,3-dinitropyrene	3829965	CTD
2	1,6-dinitropyrene	2855872 3829965 8603480	CTD
3	1,8-dinitropyrene	View details 1649014 2855872 3829965 8603480	CTD
4	1-(2-hydroxyethyl)-1-nitrosourea	3468300	CTD
5	1-amyl-1-nitrosourea	7191813	CTD
6	1-nitropyrene	3829965 8603480	CTD
7	2',3-dimethyl-4-aminobiphenyl	6943385	CTD
8	3-methyl-2-naphthylamine	6943385	CTD
9	ABT-737	20038611	CTD
10	Daunorubicin	423182	CTD
11	Imatinib Mesylate	18358458	CTD
12	propargyl alcohol	24035744	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Sarcoma, Experimental	41.3%
2	Melanoma, Experimental	39.6%
3	Mammary Neoplasms, Experimental	39.3%
4	Carcinoma 256, Walker	31.2%
5	Carcinoma, Ehrlich Tumor	29.7%
6	Carcinoma, Lewis Lung	29.7%
7	Liver Neoplasms, Experimental	28.5%
8	Leukemia, Plasma Cell	26.5%
9	Sarcoma, Myeloid	26.5%
10	Neoplasms, Neuroepithelial	25.4%
11	Gliomatosis cerebri	25.4%
12	Medulloblastoma	24.4%
13	Neuroectodermal Tumors	24.2%
14	Leukemia, Radiation-Induced	23.3%
15	melanoma	23.1%
16	Sarcoma 180	22.6%
17	Neoplasms, Germ Cell and Embryonal	22.2%
18	Neoplasms, Glandular and Epithelial	22.2%
19	Germ Cell Cancer	22.2%
20	Carcinosarcoma	21.3%
21	Hemangiosarcoma	21.3%
22	lymphangiosarcoma	21.3%
23	Adenoma, Acidophil	20.8%
24	Ganglioneuroma	20.8%
25	Glioma	20.8%
26	Malignant Glioma	20.8%
27	Meningioma	20.3%
28	Carcinoid Tumor	19.6%
29	Neurilemmoma	19.6%
30	Hutchinson's Melanotic Freckle	19.6%
31	Melanoma, Amelanotic	19.6%
32	Hamartoma	19.5%
33	Neoplasms, Hormone-Dependent	19.5%
34	Neoplasms, Multiple Primary	19.5%
35	Paraneoplastic Syndromes	19.5%
36	Precancerous Conditions	19.5%
37	Neoplasms, Second Primary	19.5%
38	Dermoid Cyst	18.9%
39	Basal cell carcinoma	18.5%
40	Carcinoma, Papillary	18.5%
41	Squamous cell carcinoma	18.5%
42	Chondrosarcoma	18.5%
43	Craniopharyngioma	18.5%
44	Cystadenoma	18.5%
45	leiomyosarcoma	18.5%
46	liposarcoma	18.5%
47	Mesothelioma	18.5%
48	synovial sarcoma	18.5%
49	Neuroectodermal Tumor, Melanotic	18.5%
50	Angiomyolipoma	18.5%
51	Clear Cell Sarcoma of Soft Tissue	18.5%
52	Alveolar Soft Part Sarcoma	18.5%
53	Neuroendocrine Tumors	18.5%
54	Carcinoma, Basal Cell	18.5%
55	Astrocytoma	18.5%
56	Ependymoma	18.5%
57	oligodendroglioma	18.5%
58	Ganglioglioma	18.5%
59	gliosarcoma	18.5%
60	Anaplastic astrocytoma	18.5%
61	Anaplastic Oligodendroglioma	18.5%
62	Trophoblastic Neoplasms	18.1%
63	Malignant Carcinoid Syndrome	17.9%
64	Histiocytic Disorders, Malignant	17.7%
65	Glioblastoma	17.3%
66	Neuroblastoma	17.3%
67	Glioblastoma Multiforme	17.3%
68	Leukemia, Myelomonocytic, Chronic	17.2%
69	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	17.2%
70	Cystadenocarcinoma	17.2%
71	Fibrosarcoma	17.2%
72	Osteosarcoma	17.2%
73	Mucoepidermoid Carcinoma	17.2%
74	Composite Lymphoma	17.1%
75	Choriocarcinoma	16.9%
76	Carcinoma, Lobular	16.9%
77	Ganglioneuroblastoma	16.8%
78	Adenofibroma	16.5%
79	Fibroadenoma	16.5%
80	Malignant Fibrous Histiocytoma	16.5%
81	Multiple Endocrine Neoplasia	16.3%
82	Acanthoma	16%
83	Bowen's Disease	15.8%
84	Paraganglioma	15.8%
85	Rhabdomyosarcoma	15.8%
86	Giant Cell Tumor of Bone	15.8%
87	Cyst	15.6%
88	Neoplastic Processes	15.6%
89	Neoplastic Syndromes, Hereditary	15.6%
90	Pregnancy Complications, Neoplastic	15.6%
91	Retinoblastoma	15.2%
92	Adenoma	15.1%
93	Ameloblastoma	15.1%
94	Angiokeratoma	15.1%
95	Carcinoma	15.1%
96	Chordoma	15.1%
97	Hemangioma	15.1%
98	hemangiopericytoma	15.1%
99	Lymphangioma	15.1%
100	Mesenchymoma	15.1%
101	Nevus	15.1%
102	Teratoma	15.1%
103	Hepatoblastoma	15.1%
104	Mixed Tumor, Mullerian	15.1%
105	Germinoma	15.1%
106	Teratocarcinoma	15.1%
107	Angiofibroma	15.1%
108	Sarcoma	15.1%
109	Epithelioma	15.1%
110	Dermatofibrosarcoma	15.1%
111	Dermatofibrosarcoma Protuberans	15.1%
112	Carcinoid Heart Disease	14.8%
113	Lymphoma	14.7%
114	Leukemia, Myeloid, Chronic-Phase	14.5%
115	Thymoma	14.4%
116	Pheochromocytoma	14.4%
117	Alveolar rhabdomyosarcoma	14.4%
118	Leukemia, T-Cell	14.3%
119	Leukemia, B-Cell	14.3%
120	Neurofibrosarcoma	14.2%
121	Liver Cirrhosis, Experimental	14.1%
122	Arthritis, Experimental	14.1%
123	Endometrial Stromal Sarcoma	14%
124	Paraneoplastic Encephalomyelitis	13.7%
125	Lymphangioleiomyomatosis	13.1%
126	Acoustic Neuroma	13.1%
127	Carcinoma, Pancreatic Ductal	12.8%
128	Neoplasms, Radiation-Induced	12.8%
129	Basal Cell Nevus Syndrome	12.4%
130	Lymphomatoid Granulomatosis	12.3%
131	Plasmacytoma	12.1%
132	Malignant histiocytosis	12%
133	Histiocytic sarcoma	12%
134	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	12%
135	Leukemia, Large Granular Lymphocytic	12%
136	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	12%
137	Abdominal Neoplasms	12%
138	Erythroplasia	12%
139	Follicular cyst	12%
140	Head and Neck Neoplasms	12%
141	Mucocele	12%
142	Pilonidal Cyst	12%
143	Soft Tissue Neoplasms	12%
144	Thoracic Neoplasms	12%
145	Thyroglossal Cyst	12%
146	Synovial Cyst	12%
147	Aberrant Crypt Foci	12%
148	Tuberous Sclerosis	11.9%
149	Optic Nerve Glioma	11.8%
150	Diabetes Mellitus, Experimental	11.8%
151	Nephroblastoma	11.7%
152	Vipoma	11.7%
153	Adenocarcinoma	11.7%
154	Carcinoma in Situ	11.7%
155	Carcinoma, Transitional Cell	11.7%
156	Phyllodes Tumor	11.7%
157	Dysgerminoma	11.7%
158	Hemangioendothelioma	11.7%
159	Lipoma	11.7%
160	Myoma	11.7%
161	Myxoma	11.7%
162	Neuroma	11.7%
163	Papilloma	11.7%
164	Pseudomyxoma Peritonei	11.7%
165	Seminoma	11.7%
166	Papillomatosis	11.7%
167	Angiolipoma	11.7%
168	Myelolipoma	11.7%
169	Neoplasms, Bone Tissue	11.7%
170	Neoplasms, Fibrous Tissue	11.7%
171	Smooth Muscle Tumor	11.7%
172	Adenomatosis, Pulmonary	11.7%
173	Adenomatous Polyps	11.7%
174	Carcinoma, Large Cell	11.7%
175	Carcinoma, Small Cell	11.7%
176	Desmoplastic Small Round Cell Tumor	11.7%
177	Chondroma	11.7%
178	Enchondroma	11.7%
179	Multiple Endocrine Neoplasia Type 1	11.6%
180	Hydatidiform Mole	10.9%
181	Hepatocellular Adenoma	10.4%
182	Adenoid Cystic Carcinoma	10%
183	fibroma	10%
184	Fibromatosis	10%
185	Osteoblastoma	10%
186	Osteoma	10%
187	Rhabdomyoma	10%
188	Chondromatosis	10%
189	Adenocarcinoma, Clear Cell	10%
190	Cholangiocarcinoma	10%
191	Cervical Intraepithelial Neoplasia	10%
192	Hemangioblastoma	10%
193	Lymphoma, Extranodal NK-T-Cell	10%
194	Hodgkin Disease	9.9%
195	Lymphoma, Non-Hodgkin	9.9%
196	Digestive System Neoplasms	9.9%
197	Endocrine Gland Neoplasms	9.9%
198	Eye Neoplasms	9.9%
199	Nervous System Neoplasms	9.9%
200	Parathyroid Neoplasms	9.8%
201	Peritoneal Neoplasms	9.8%
202	Thyroid Neoplasm	9.8%
203	Thyroid carcinoma	9.8%
204	Bone neoplasms	9.7%
205	Leukoplakia	9.7%
206	Lymphocele	9.7%
207	Pancreatic Cyst	9.7%
208	Skin Neoplasms	9.7%
209	Hematologic Neoplasms	9.7%
210	Barrett Esophagus	9.5%
211	Breast Cyst	9.5%
212	Actinic keratosis	9.5%
213	Mediastinal Cyst	9.5%
214	Neoplasm Invasiveness	9.5%
215	Neoplasm Metastasis	9.5%
216	Neoplasm Recurrence, Local	9.5%
217	Parovarian Cyst	9.5%
218	Pericardial Cyst	9.5%
219	Splenic Neoplasms	9.5%
220	Thymic Cyst	9.5%
221	Carcinogenesis	9.5%
222	Myxoid cyst	9.5%
223	Metastasis	9.5%
224	insulinoma	9.4%
225	Fibromatosis, Aggressive	9.1%
226	Fibromatosis, Abdominal	9.1%
227	Klatskin Tumor	9.1%
228	Mesoblastic Nephroma	9.1%
229	Prolactinoma	9.1%
230	Growth Hormone-Secreting Pituitary Adenoma	9.1%
231	Gastrinoma	9%
232	Glucagonoma	9%
233	Adenomatous Polyposis Coli	8.8%
234	Tracheal Neoplasms	8.7%
235	Radiation Injuries, Experimental	8.7%
236	Pancreatic Neoplasm	8.6%
237	Leukoplakia, Oral	8.6%
238	Primary amyloidosis	8.6%
239	Paraneoplastic Cerebellar Degeneration	8.5%
240	Retroperitoneal Neoplasms	8.4%
241	Leydig Cell Tumor	8.2%
242	granulosa cell tumor	8%
243	Carcinoma, Ovarian Epithelial	8%
244	Mastocytoma	8%
245	Device Failure	8%
246	Mastocytosis, Systemic	7.9%
247	Mastocytosis	7.9%
248	Sturge-Weber Syndrome	7.9%
249	Corpus Luteum Cyst	7.8%
250	Ovarian Cysts	7.8%
251	Gastrointestinal Stromal Tumors	7.8%
252	Adrenocortical carcinoma	7.8%
253	Hemangioma, Cavernous	7.7%
254	neurofibroma	7.7%
255	Lymphoma, Follicular	7.7%
256	T-Cell Lymphoma	7.7%
257	Mantle cell lymphoma	7.7%
258	Thyroid Nodule	7.6%
259	Esophageal Neoplasms	7.5%
260	Limbic Encephalitis	7.4%
261	Neoplasms, Experimental	7%
262	Electrophoresis	6.9%
263	Renal Cell Carcinoma	6.9%
264	Papillary Renal Cell Carcinoma	6.9%
265	leukemia	6.8%
266	Choledochal Cyst	6.8%
267	Mouth Neoplasms	6.8%
268	Central Nervous System Neoplasms	6.8%
269	Vascular Neoplasms	6.8%
270	Thymus Neoplasms	6.8%
271	Leukemia, Experimental	6.7%
272	Lambert-Eaton Myasthenic Syndrome	6.7%
273	Testicular Neoplasms	6.7%
274	Genital Neoplasms, Female	6.7%
275	Pancreatic Pseudocyst	6.7%
276	Nasopharyngeal carcinoma	6.7%
277	Peutz-Jeghers Syndrome	6.7%
278	Lymphatic Metastasis	6.7%
279	Neoplasms, Unknown Primary	6.7%
280	Leukemic Infiltration	6.7%
281	Breast Neoplasms, Male	6.7%
282	Neoplasm Micrometastasis	6.7%
283	Triple Negative Breast Neoplasms	6.7%
284	Carcinoma, Endometrioid	6.6%
285	Waldenstrom Macroglobulinemia	6.6%
286	Multiple Myeloma	6.6%
287	Neuritis, Autoimmune, Experimental	6.6%
288	Denys-Drash Syndrome	6.6%
289	Intubation	6.6%
290	Lymphoma, T-Cell, Cutaneous	6.5%
291	Lymphoma, AIDS-Related	6.5%
292	Enteropathy-Associated T-Cell Lymphoma	6.5%
293	Primary Effusion Lymphoma	6.5%
294	Cytogenetic Analysis	6.3%
295	Dupuytren Contracture	6.2%
296	Urticaria Pigmentosa	6.1%
297	Opsoclonus-Myoclonus Syndrome	6%
298	Leukemia L1210	6%
299	Leukemia P388	6%
300	Mycosis Fungoides	6%
301	Lymphomatoid Papulosis	6%
302	Plasmablastic lymphoma	6%
303	Adrenal Gland Neoplasms	5.7%
304	Gastrointestinal Neoplasms	5.7%
305	Genital Neoplasms, Male	5.7%
306	Liver neoplasms	5.7%
307	Uveal Neoplasms	5.7%
308	Urologic Neoplasms	5.6%
309	Sebaceous Gland Neoplasms	5.6%
310	Spinal Neoplasms	5.6%
311	Bone Marrow Neoplasms	5.6%
312	Polycystic Ovary Syndrome	5.5%
313	Palatal Neoplasms	5.5%
314	Nose Neoplasms	5.4%
315	Myelitis, Transverse	5.4%
316	Meningeal Neoplasms	5.3%
317	Autopsy	5.2%
318	Microscopy	5.2%
319	Myasthenia Gravis, Autoimmune, Experimental	5.1%
320	Burkitt Lymphoma	4.9%
321	Pituitary Adenoma	4.9%
322	Pituitary Neoplasms	4.9%
323	Meningeal Carcinomatosis	4.6%
324	Ear Neoplasms	4.5%
325	Eyelid Neoplasms	4.5%
326	Lung Neoplasms	4.5%
327	Pleural Neoplasms	4.5%
328	Sezary Syndrome	4.5%
329	Cell Transformation, Viral	4.5%
330	Brain Neoplasms	4.4%
331	Salivary Gland Neoplasms	4.4%
332	Spinal Cord Neoplasms	4.4%
333	Tongue Neoplasms	4.4%
334	Uterine Neoplasms	4.4%
335	Vaginal Neoplasms	4.4%
336	Vulvar Neoplasms	4.4%
337	Uterine Cancer	4.4%
338	Fallopian Tube Neoplasms	4.4%
339	Xeroderma Pigmentosum	4.3%
340	Gastric Lavage	4.3%
341	Peritoneal lavage	4.3%
342	Bronchoalveolar Lavage	4.3%
343	ovarian neoplasm	4.2%
344	Bronchial Neoplasms	3.9%
345	Pharyngeal Neoplasms	3.9%
346	Multiple Pulmonary Nodules	3.9%
347	Central Nervous System Cysts	3.8%
348	Supratentorial Neoplasms	3.8%
349	Endometrial Neoplasms	3.8%
350	Bile Duct Neoplasms	3.8%
351	gallbladder neoplasm	3.8%
352	Intestinal Neoplasms	3.8%
353	Penile Neoplasms	3.8%
354	Prostatic Neoplasms	3.8%
355	Stomach Neoplasms	3.8%
356	Polycythemia Vera	3.8%
357	Brain Stem Neoplasms	3.5%
358	Laryngeal neoplasm	3.4%
359	Prosthesis Failure	3.4%
360	Choroid Plexus Papilloma	3.4%
361	Immunosuppression	3.4%
362	Hypopharyngeal Neoplasms	3.3%
363	Pleural Effusion, Malignant	3.3%
364	Hypopharyngeal Cancer	3.3%
365	Zollinger-Ellison syndrome	3.3%
366	Bladder Neoplasm	3.3%
367	Kidney Neoplasm	3.3%
368	Ureteral Neoplasms	3.3%
369	Urethral Neoplasms	3.3%
370	Parotid Neoplasms	3.3%
371	Prostatic Neoplasms, Castration-Resistant	3.3%
372	Nelson Syndrome	3.3%
373	Tonsillar Neoplasms	3%
374	Cerebellar Neoplasms	3%
375	Glasgow coma scale	2.9%
376	Cecal Neoplasms	2.9%
377	Duodenal Neoplasms	2.9%
378	Biopsy	2.7%
379	Radicular Cyst	2.7%
380	Appendiceal Neoplasms	2.6%
381	Colonic Neoplasms	2.6%
382	Rectal Neoplasms	2.6%
383	Nasopharyngeal Neoplasms	2.6%
384	Colorectal Neoplasms	2.5%
385	Polymerase Chain Reaction	2.5%
386	Angioplasty	2.4%
387	Paranasal Sinus Neoplasms	2.3%
388	Amniocentesis	2.3%
389	Anus Neoplasms	2.2%
390	Sigmoid Neoplasms	2.2%
391	Tuberculin Test	2.2%
392	Maxillary Sinus Neoplasms	2.1%
393	Ovulation Induction	2%
394	Blood culture	2%
395	Immunoglobulin Therapy	2%
396	Leukapheresis	1.4%
397	Atherectomy	1.4%
398	Body mass index	1.4%
399	Paracentesis	1.1%
400	PROTHROMBIN TIME	1.1%
401	Glucose tolerance test	1.1%
402	Superovulation	1.1%
403	Clot retraction	1.1%
404	venipuncture	1%
405	Body Height	0.9%
406	Body Weight	0.8%
407	Birth Weight	0.6%
408	Fetal Weight	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234